Lawmakers open investigation into FDA’s handling of drug shortages

The Hill (11/3, Weixel) reported Republican lawmakers in the House “are launching a probe into how the Food and Drug Administration (FDA) is responding to a growing number of prescription drug shortages in the country.” House Committee on Oversight and Accountability members wrote a letter to FDA Commissioner Robert Califf, MD, that “requested documents and a staff-level briefing to understand the agency’s role in monitoring drug shortages and mitigation strategies.” According to the FDA “drug tracker,” there are “nearly 130 drugs currently in short supply, including generic cancer drugs, amoxicillin, albuterol and Adderall. Earlier this year, there was a shortage of children’s acetaminophen and ibuprofen.”

Related Links:

— “House GOP opens probe into FDA response to drug shortages,”Nathaniel Weixel, The Hill, November 3, 2023

Posted in In The News.